Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
24.95
+0.64 (2.63%)
Nov 21, 2024, 11:41 AM EST - Market open
Rigel Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 3.88 | -25.09 | -58.57 | -17.91 | -29.74 | -66.89 | Upgrade
|
| Depreciation & Amortization | 1.92 | 1.24 | 1 | 1.16 | 0.71 | 0.68 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | 0.27 | -0.14 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.69 | -0.48 | -0.06 | 0.29 | -0.12 | -1.07 | Upgrade
|
| Stock-Based Compensation | 12.24 | 8.81 | 12.39 | 9.49 | 7.3 | 9.12 | Upgrade
|
| Other Operating Activities | - | - | 0.68 | 3.14 | - | - | Upgrade
|
| Change in Accounts Receivable | -7.03 | 9.77 | -24.85 | 0.5 | -5.86 | -6.03 | Upgrade
|
| Change in Inventory | 1.37 | 1.17 | -2.38 | -4.88 | -0.13 | -0.37 | Upgrade
|
| Change in Accounts Payable | -4.18 | -0.37 | 3.79 | 0.04 | -0.33 | -2.24 | Upgrade
|
| Change in Unearned Revenue | - | -0.01 | -1.23 | -0.42 | -23.63 | 24.26 | Upgrade
|
| Change in Other Net Operating Assets | 3.36 | -1.05 | -4.39 | 14.47 | -0.37 | 1.04 | Upgrade
|
| Operating Cash Flow | 10.73 | -5.74 | -73.76 | 5.88 | -52.19 | -41.51 | Upgrade
|
| Capital Expenditures | -0.01 | - | -0.45 | -0.63 | -1.26 | -1.46 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | 0.26 | 0.89 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.36 | -15 | - | - | - | - | Upgrade
|
| Investment in Securities | 8.4 | 10.44 | 72.33 | -79.41 | 48.73 | -22.2 | Upgrade
|
| Investing Cash Flow | 8.17 | -4.3 | 72.78 | -80.04 | 47.47 | -23.66 | Upgrade
|
| Long-Term Debt Issued | - | 19.95 | 19.54 | - | 9.98 | 9.79 | Upgrade
|
| Net Debt Issued (Repaid) | - | 19.95 | 19.54 | - | 9.98 | 9.79 | Upgrade
|
| Issuance of Common Stock | 0.99 | 1.05 | 2.12 | 62.68 | 2.6 | 1.58 | Upgrade
|
| Other Financing Activities | -13.61 | -2.63 | -15.12 | - | - | - | Upgrade
|
| Financing Cash Flow | -12.62 | 18.37 | 6.55 | 62.68 | 12.57 | 11.37 | Upgrade
|
| Net Cash Flow | 6.28 | 8.33 | 5.57 | -11.48 | 7.85 | -53.8 | Upgrade
|
| Free Cash Flow | 10.72 | -5.74 | -74.21 | 5.25 | -53.45 | -42.97 | Upgrade
|
| Free Cash Flow Margin | 6.81% | -4.96% | -64.12% | 3.78% | -49.21% | -72.47% | Upgrade
|
| Free Cash Flow Per Share | 0.61 | -0.33 | -4.30 | 0.31 | -3.17 | -2.57 | Upgrade
|
| Cash Interest Paid | 6.97 | 5.85 | 2.5 | 1.5 | 1.18 | 0.14 | Upgrade
|
| Levered Free Cash Flow | 13.14 | -25.82 | -39.83 | 10.44 | -41.66 | -24.32 | Upgrade
|
| Unlevered Free Cash Flow | 18.05 | -21.52 | -37.52 | 13.47 | -40.82 | -24.11 | Upgrade
|
| Change in Net Working Capital | 1.61 | 3.07 | 13.74 | -15.63 | 29.45 | -10.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.